What does BIO-TECHNE Corp (TECH) do?

BIO-TECHNE Corp (TECH) is a publicly traded company in the Healthcare sector.

What sector does TECH operate in?

BIO-TECHNE Corp operates in the Healthcare, specifically within the Biotechnology industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find TECH earnings analysis?

AlphaOS publishes an earnings intelligence page for BIO-TECHNE Corp (TECH) covering results, guidance context, and AI-assisted analysis. See /stocks/TECH/earnings. Content is for research and education — not investment advice.

TECH

BIO-TECHNE Corp

Healthcare · Biotechnology

$72.51Sep 28, 2026

AI confidence 70% · refreshes every 15s during session

Investment Snapshot

Strong evidence · 3 sources

Why it matters

BIO-TECHNE Corp shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +1% YoY in Q4 FY2026.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +1% YoY in Q4 FY2026
Revenue Comparability Impaired by Divestiture

Pipeline evidence · 0d ago

TECH's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on TECH.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q4 2026

Full TECH earnings analysis

Reported figures for BIO-TECHNE Corp — research only, not investment advice.

Revenue YoY: +1.3%
EPS YoY: +45.8%

Latest Intelligence

Updated September 29, 2026

What happened recently for BIO-TECHNE Corp (TECH) — events, not interpretation.

Event: Reported Q4 2026 revenue +1% YoY.
Also: Last session September 28, 2026 at $72.51.
Source: Q4 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

BIO-TECHNE Corp (TECH)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for BIO-TECHNE Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biotechnology
Market cap:: $11.37B
Revenue:: $321.19M

TECH earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow BIO-TECHNE Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.